(3-(1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)PHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 10g

Acétonitrile D3, 99,8 at%D, 7,5 ml, emballage en verreamp.

7-Benzyl-4-(4-(trifluoromethyl)benzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, 98%, 250mg

5-Bromo-6-phenylpyridazin-3(2H)-one, 95.0%, 10g

Oxetan-3-ylmethanol, 95.0%, 250mg

(E)-3-(dimethylamino)-1-(imidazo[1,2-a]pyridin-3-yl)prop-2-en-1-one, 98%, 25g

2-Amino-6-tert-butyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 98.0%, 500mg

Colonne capillaire GC ROTI®Cap-FFAP, 50 m, 0,32 mm, 0,50 µm, 1 pièce(s)

4-(2-CHLORO-6-METHYLTHIENO[3,2-D]PYRIMIDIN-4-YL)MORPHOLINE, 95.0%, 100mg

Flacons de culture en forme d'Erlenmeyer, 500 ml 10 pcs

Decahydro-1,4-naphthalenedicarboxylic Acid (mixture of isomers)>96.0%(GC)(T)1g

N-Benzyloxetan-3-amine oxalate, 95.0%, 1g

5,7-Dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid, 95.0%, 1g